# Royalty Pharma PLC RPRX 5.9 09/02/54

Royalty Pharma PLC RPRX 5.9 09/02/54 is a security (CUSIP 78081BAS2) tracked across SEC portfolio filings. 2 registered fund positions totaling $802K via N-PORT as of 2026-04-30.

## Summary

- Issuer: Royalty Pharma PLC
- Class: RPRX 5.9 09/02/54
- CUSIP: 78081BAS2
- Asset category: DBT
- 13F holders: 0
- N-PORT fund positions: 2
- N-PORT value: $802K
- N-PORT report: 2026-04-30

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [BlackRock Total Return Fund](https://search.stillhousedata.com/fund/S000004071) | BlackRock Bond Fund, Inc. | $433K | 0.24% |
| [Transamerica Long Credit](https://search.stillhousedata.com/fund/S000080097) | TRANSAMERICA FUNDS | $369K | 23.53% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/78081BAS2.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.